Sign In
Buy AIM
$0.732
-0.0947 (-11.46%)
At Close: Jun 03, 2026
Cornish Metals Inc ("Cornish Metals" or the "Company") (AIM/TSX-V: CUSN) Result of Retail Offer
01:00pm, Friday, 31'st Jan 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, O
Cornish Metals Inc (AIM/TSX-V: CUSN) ("Cornish Metals" or the "Company") Result of Fundraising
08:53am, Tuesday, 28'th Jan 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTIO
Polarean Imaging inks partnership with US outpatient medical imaging firm
03:08am, Tuesday, 28'th Jan 2025
Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) is teaming up with SimonMed Imaging, one of America's largest outpatient medical imaging providers. It will see the AIM-quoted firm's Xenon MRI platform deli
OCALA, Fla., Jan. 23, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the final Clinical Study Results for the “Study to Eval
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
08:30am, Wednesday, 22'nd Jan 2025
Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS
AIM ImmunoTech (AIM) Upgraded to Strong Buy: What Does It Mean for the Stock?
01:01pm, Friday, 17'th Jan 2025
AIM ImmunoTech (AIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Deltex Medical shares plunge 50% on proposed AIM cancellation and CEO resignation
04:45am, Thursday, 16'th Jan 2025
Shares in Deltex Medical Group plc (AIM:DEMG) (AIM: DEMG) fell 50% following the announcement of a proposed delisting from AIM and leadership changes. The company attributed its decision to delist to
AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones
09:05am, Wednesday, 15'th Jan 2025
– Continued execution across Ampligen® (rintatolimod) clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer and Long-COVID spaces
Plantible is a vertically integrated biology company unlocking the potential of duckweed to create a plant-based protein that emulates the characteristics of animal-based proteins CH4 Global is scalin
Orosur Mining Inc Announces Exercise of Warrants
02:00am, Monday, 06'th Jan 2025
Orosur Mining Inc Exercise of Warrants, Issue of Shares and Total Voting Rights LONDON, UNITED KINGDOM / ACCESSWIRE / January 6, 2025 / Orosur Mining Inc. ("Orosur" or "the Company") (AIM/TSXV:OMI), a
AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
04:45pm, Tuesday, 17'th Dec 2024
OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that it received a notice (the “Notice”) from the NYSE Am
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
03:10pm, Tuesday, 17'th Dec 2024
OCALA, Fla.--(BUSINESS WIRE)--AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that, based on the preliminary vote count of its proxy solicitor, shareholders h
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
08:00am, Monday, 16'th Dec 2024
OCALA, Fla.--(BUSINESS WIRE)--AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today issued the following statement in connection with the upcoming 2024 Annual Meeting of Stoc
Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
04:54pm, Saturday, 14'th Dec 2024
Vote “ FOR ” All Four Kellner Group Nominees Today on Gold Card for Urgently Needed Change
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
03:48pm, Friday, 13'th Dec 2024
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions
